Leaderboard

En | De
No articles selected!     View Cart  
You are here: Gastroenterology » Gastrointestinal » Inflammatory Bowel Disease 20. October 2026
Search
medline.ch
Inflammatory Bowel Disease
Advanced search
Dermatology
Endocrinology
Nutrition
Gastroenterology
Biliary Tract
Liver
Gastrointestinal
Diarrhea
Inflammatory Bowel Disease
Functional Diseases
Gastroenteritis
Gastrointestinal Hemorrhage
Neoplasms
Peptic Ulcer
Others
Esophagus
Pankreas
Gynecology
Haematology
Infectious diseases
Cardiovascular Diseases
Musculoskeletal Diseases
Neurology
Oncology
ORL
Pediatrics
Psychiatry
Respiratory Tract
Sports
Urology-Nephrology
Rect Top
Zoom: Zoom In Zoom Out

   Page 1 of 2958  Previews Next
   
   Articles 1 - 20 / 59149  
   
GART expression is associated with a proliferative and purine-metabolic ISC-like epithelial state in ulcerative colitis.
Front Immunol
Chong J, Ding H, Ma J, Li Y, Pan J, Li Y, Chen Y.
PMID: 42898284 [PubMed - indexed for MEDLINE]


Integrated genetic and functional analyses reveal the pathogenic effects of a novel STXBP3 variant in very-early-onset inflammatory bowel disease with immunodeficiency.
Front Immunol
Pan C, Zhang P, Tang W, Wang S, Huang Z, Lu X, Meng Y, Xia H, Wang L, Huang Y.
PMID: 42898147 [PubMed - indexed for MEDLINE]


Diagnostic accuracy of Neutrophil Gelatinase-Associated Lipocalin (NGAL) for inflammatory bowel disease: a systematic review and bivariate diagnostic meta-analysis.
BMC Gastroenterol
Yu T, Meng F, Ma K, Wang C.
PMID: 42897465 [PubMed - indexed for MEDLINE]


Comparative risk of incident Clostridioides difficile infection with vedolizumab versus anti‑TNF in ulcerative colitis: A retrospective cohort study.
Dig Liver Dis
Huang J, Jiang Z, Deng J, Yao J, Peng X, Zhang Q, Zhi M, Zhang M, Liu T.
PMID: 42897030 [PubMed - as supplied by publisher]


Safety and tolerability of anti-toll-like receptor 3, monoclonal antibody PRV-300 in patients with moderate-to-severe ulcerative colitis: a randomized phase 1B clinical trial (PULSE).
J Crohns Colitis
Pokryszka J, Comer GM, Richmond CA, Leon F, Reinisch W.
PMID: 42896861 [PubMed - indexed for MEDLINE]


Paediatric Helicobacter pylori infection and allergic and inflammatory diseases: a contemporary systematic review with meta-analysis.
Eur J Pediatr
Tavares M, Ferreira A, Campo E, Santos Silva E, Lima R, Lopes AI.
PMID: 42895565 [PubMed - indexed for MEDLINE]


Switching from Intravenous to Subcutaneous Infliximab in Children with Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis.
Curr Gastroenterol Rep
Spencer EA.
PMID: 42891908 [PubMed - indexed for MEDLINE]


Filgotinib in Ulcerative Colitis: Long-term Outcomes and Treatment Positioning.
J Vis Exp
Zhong H, Ma X, Jiao Y.
PMID: 42891591 [PubMed - indexed for MEDLINE]


Release and Targeting Mechanism of Nanomedicine Delivery System in Inflammatory Bowel Disease.
Int J Nanomedicine
Wang H, Zhou F, Shen M, Zhou S, Ma R, Yu Q.
PMID: 42890836 [PubMed - indexed for MEDLINE]


Determination of the approach of Polish gastroenterologists and surgeons to the diagnosis and treatment of complex cases of Crohn's disease-related perianal fistulas.
Prz Gastroenterol
Eder P, Banasiewicz T, G, Regu, Rydzewska G, Wallner G, Dziki AJ.
PMID: 42889747 [PubMed]


Effectiveness of curcumin in achieving clinical remission and reducing disease activity in ulcerative colitis: a randomised, controlled trial.
Prz Gastroenterol
Abdulah DM, Mohammed AS.
PMID: 42889712 [PubMed]


Metastatic Crohn's disease unmasked: from elusive skin clues to diagnosis and treatment - a comprehensive review.
Prz Gastroenterol
Nitskovich R, Lewandowski K, Rydzewska G, Walecka I.
PMID: 42889428 [PubMed]


Noninvasive Biomarkers for Early Detection of Primary Sclerosing Cholangitis in Ulcerative Colitis.
Biomed Res Int
Asadi Sarabi P, Beheshti-Maal A, Judaki AA, Teymoorian SK, Hashemian Z, Rismani E, Gul A, Malekzadeh R, Hassan M, Vosough M.
PMID: 42888975 [PubMed - indexed for MEDLINE]


Objective validation of the Crohn's Anal Fistula Quality of Life questionnaire using quantitative MRI fistula volume in perianal fistulising Crohn's disease.
Colorectal Dis
Anand E, Pelly T, Patel U, Callan R, Kanani R, Hart A, Tozer P, Lung P.
PMID: 42888942 [PubMed - indexed for MEDLINE]


The Hidden Conductor: HDL-Gut Microbiome Interplay in the Pathophysiology of Inflammatory-Based Diseases.
Biofactors
Hafiane A, Kiss RS, Favari E, Amedei A, Parolini C.
PMID: 42888923 [PubMed - indexed for MEDLINE]


International expert consensus on managing elective hernia repair in patients with Crohn's disease using the Delphi method.
BJS Open
Lovén H, Helgstrand F, Friis-Andersen H, Ballecer C, Berrevoet F, Boermeester M, de la Croix H, Gaarder C, Gögenur I, Henriksen N, Hope W, Itani K, Jřrgensen LN, Köckerling F, Lambrecht JR, Miserez M, Petersson U, Pinkney T, Poulose BK, Rosen M, Rosenberg J, Sanders DL, Slade D, Törnqvist B, Bisgaard T.
PMID: 42888871 [PubMed - indexed for MEDLINE]


Relationship between vitamin D serum concentration and inflammatory bowel disease demographics: A cross-sectional study.
Medicine (Baltimore)
Shehab M, AlSayegh A, Ziyab AH.
PMID: 42888630 [PubMed - indexed for MEDLINE]


Separating Prognostic Association from Treatment-Effect Modification of a Baseline Mucosal Inflammatory-Response Score in Ulcerative Colitis Biologic Trials.
Clin Res Hepatol Gastroenterol
Jiang M, Meng Q, Xue L.
PMID: 42887763 [PubMed - as supplied by publisher]


Defining and measuring disease burden in Crohn's disease: a systematic literature review.
Scand J Gastroenterol
Radford SJ, Olsen BJ, Noor NM, Crooks CJ, Segal J, Lindsay JO, Panaccione R, Moran G.
PMID: 42886577 [PubMed - as supplied by publisher]


GLP-1 receptor agonists and symptomatic remission in ulcerative colitis: A credible signal that welcomes prospective study.
Inflamm Bowel Dis
Alqinai B, Gayam S, Hadam-Veverka J.
PMID: 42886561 [PubMed - as supplied by publisher]


   
   Articles 1 - 20 / 59149    Page 1 of 2958  Previews Next

 
Rect Bottom
Adserver Footer
 

  Time frame  
   

Sky right 1